Interesting People mailing list archives

Swift Gene-Editing Method May Revolutionize Treatments for Cancer and Infectious Diseases


From: "Dave Farber" <farber () gmail com>
Date: Thu, 12 Jul 2018 19:00:14 +0900



Begin forwarded message:

From: Dewayne Hendricks <dewayne () warpspeed com>
Subject: [Dewayne-Net] Swift Gene-Editing Method May Revolutionize Treatments for Cancer and Infectious Diseases
Date: July 12, 2018 at 6:52:26 PM GMT+9
To: Multiple recipients of Dewayne-Net <dewayne-net () warpspeed com>
Reply-To: dewayne-net () warpspeed com

Swift Gene-Editing Method May Revolutionize Treatments for Cancer and Infectious Diseases
Scientists report that they have discovered a way to tweak genes in the body’s immune cells by using electrical 
fields.
By Gina Kolata
Jul 11 2018
<https://www.nytimes.com/2018/07/11/health/gene-editing-cancer.html>

For the first time, scientists have found a way to efficiently and precisely remove genes from white blood cells of 
the immune system and to insert beneficial replacements, all in far less time than it normally takes to edit genes.

If the technique can be replicated in other labs, experts said, it may open up profound new possibilities for 
treating an array of diseases, including cancer, infections like H.I.V. and autoimmune conditions like lupus and 
rheumatoid arthritis. 

The new work, published on Wednesday in the journal Nature, “is a major advance,” said Dr. John Wherry, director of 
the Institute of Immunology at the University of Pennsylvania, who was not involved in the study. 

But because the technique is so new, no patients have yet been treated with white blood cells engineered with it. 

“The proof will be when this technology is used to develop a new therapeutic product,” cautioned Dr. Marcela Maus, 
director of cellular immunotherapy at Massachusetts General Hospital. 

That test may not be far away. The researchers have already used the method in the laboratory to alter the abnormal 
immune cells of children with a rare genetic condition. They plan to return the altered cells to the children in an 
effort to cure them. 

Currently, scientists attempting to edit the genome often must rely on modified viruses to slice open DNA in a cell 
and to deliver new genes into the cell. The method is time-consuming and difficult, limiting its use.

Despite the drawbacks, the virus method has had some success. Patients with a few rare blood cancers can be treated 
with engineered white blood cells — the immune system’s T-cells — that go directly to the tumors and kill them. 

This type of treatment with engineered white cells, called immunotherapy, has been limited because of the difficulty 
of making viruses to carry the genetic material and the time needed to create them.

But researchers now say they have a found a way to use electrical fields, not viruses, to deliver both gene-editing 
tools and new genetic material into the cell. By speeding the process, in theory a treatment could be available to 
patients with almost any type of cancer.

“What takes months or even a year may now take a couple weeks using this new technology,” said Fred Ramsdell, vice 
president of research at the Parker Institute for Cancer Immunotherapy in San Francisco. “If you are a cancer 
patient, weeks versus months could make a huge difference.” 

“I think it’s going to be a huge breakthrough,” he added.

The Parker Institute already is working with the authors of the new paper, led by Dr. Alexander Marson, scientific 
director of biomedicine at the Innovative Genomics Institute — a partnership between University of California, San 
Francisco and the University of California, Berkeley — to make engineered cells to treat a variety of cancers. 

In the new study, Dr. Marson and his colleagues engineered T-cells to recognize human melanoma cells. In mice 
carrying the human cancer cells, the modified T-cells went right to the cancer, attacking it.

The researchers also corrected — in the lab — the T-cells of three children with a rare mutation that caused 
autoimmune diseases. The plan now is to return these corrected cells to the children, where they should function 
normally and suppress the defective immune cells, curing the children.

The technique may also hold great promise for treating H.I.V., Dr. Wherry said. 

The H.I.V. virus infects T-cells. If  they can be engineered so that the virus cannot enter the T-cells, a person 
infected with H.I.V. should not progress to AIDS. Those T-cells already infected would die, and the engineered cells 
would replace them.

Previous research has shown it might be possible to treat H.I.V. in this way. “But now there is a really efficient 
strategy to do this,” Dr. Wherry said.

[snip]

Dewayne-Net RSS Feed: http://dewaynenet.wordpress.com/feed/
Twitter: https://twitter.com/wa8dzp






-------------------------------------------
Archives: https://www.listbox.com/member/archive/247/=now
Modify Your Subscription: https://www.listbox.com/member/?member_id=18849915
Unsubscribe Now: 
https://www.listbox.com/unsubscribe/?member_id=18849915&id_secret=18849915-a538de84&post_id=20180712060025:63CDA2CA-85BA-11E8-883C-93576AC28277
Powered by Listbox: https://www.listbox.com

Current thread: